<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00801528</url>
  </required_header>
  <id_info>
    <org_study_id>MMC-0202-07</org_study_id>
    <nct_id>NCT00801528</nct_id>
  </id_info>
  <brief_title>Diclofenac vs. Ropivacaine for Cesarean Section</brief_title>
  <official_title>The Analgesic Efficacy of Continuous Wound Instillation With Diclofenac or Ropivacaine Following Cesarean Section: a Randomized, Double-blind, Placebo Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, randomized, double blind study designed to investigate analgesic efficacy of&#xD;
      wound infusion using diclofenac or ropivacaine following Cesarean section performed via a&#xD;
      Pfannenstiel incision.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Objective: To assess the analgesic efficacy of diclofenac or ropivacaine when&#xD;
      administered via wound infusion.&#xD;
&#xD;
      Design: Prospective, randomized, double-blind, placebo-controlled study. Setting: Large&#xD;
      referral hospital. Patients: 75 women recovering from Cesarean section performed via a&#xD;
      Pfannenstiel incision.&#xD;
&#xD;
      Interventions: On completion of the surgical procedure, a 15 cm 19G infusion catheter&#xD;
      (PAINfusorâ„¢, Baxter) will be placed below the fascia. According to a computer generated&#xD;
      randomization schedule, patients will be divided into one of three treatment groups (n = 25).&#xD;
&#xD;
        -  In Group Control water for injection will be administered.&#xD;
&#xD;
        -  In Group Ropivacaine 0.2 % ropivacaine will be administered.&#xD;
&#xD;
        -  In Group Diclofenac diclofenac (300 mg/240 ml of water for injection) will be&#xD;
           administered.&#xD;
&#xD;
      During the first 6 postoperative hours, a co-investigator will administer &quot;rescue&quot; analgesia&#xD;
      (10 ml bolus of infusion drug or rescue morphine). Thereafter, the catheter will be connected&#xD;
      to an elastometric pump (LV 10 Infusor, Baxter) filled with either water for injection,&#xD;
      ropivacaine 0.2 %, or diclofenac (300 mg/240 ml water for injection). The fluid will be&#xD;
      administered as a constant infusion rate (10 mL/hr). Continuous wound infusion will be&#xD;
      continued for the subsequent 18 postoperative hours. During this 18 hour period, subcutaneous&#xD;
      morphine 4 mg will be administered on patient request for additional analgesia.&#xD;
&#xD;
      Measurements and Main Results: The following parameters will be assessed and recorded:&#xD;
&#xD;
        1. Demographic data&#xD;
&#xD;
        2. Surgical milestones(Anesthetic time, surgical time etc).&#xD;
&#xD;
        3. Incidence of failed intrathecal anesthesia&#xD;
&#xD;
        4. VAS for pain every 15 min during first 6 postoperative hours&#xD;
&#xD;
        5. Time to first pain (intrathecal anesthesia to VAS &gt; 60 mm)&#xD;
&#xD;
        6. Number of infusion events (10 mL and 5 mL)&#xD;
&#xD;
        7. Rescue morphine administration during first 6 postoperative hours.&#xD;
&#xD;
        8. Subcutaneous morphine administration during subsequent 18 postoperative hours.&#xD;
&#xD;
        9. VAS for pain.&#xD;
&#xD;
       10. The incidence of nausea and vomiting.&#xD;
&#xD;
       11. Patient satisfaction at 24 hours, postoperatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1)Pain intensity 2)&quot;Rescue&quot; analgesia requirements</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous wound instillation of ropivacaine 0.2 % at a rate set of 10 mL/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous wound instillation of diclofenac (300 mg/240 ml water for injection) at a rate set of 10 mL/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water for injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Continuous wound instillation of water for injection at a rate set of 10 mL/hr</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine, Diclofenac, Water for injection</intervention_name>
    <description>Ropivacaine 0.2 %, or diclofenac (300 mg/240 ml water for injection) or water for injection will be administered as a constant instillation rate set of 10 mL/hr for the subsequent 18 postoperative hours.</description>
    <arm_group_label>Diclofenac</arm_group_label>
    <arm_group_label>Ropivacaine</arm_group_label>
    <arm_group_label>Water for injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing Cesarean section&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A history of clinically significant disease:&#xD;
&#xD;
          -  cardiovascular&#xD;
&#xD;
          -  pulmonary&#xD;
&#xD;
          -  hepatic&#xD;
&#xD;
          -  renal&#xD;
&#xD;
          -  neurologic&#xD;
&#xD;
          -  psychiatric&#xD;
&#xD;
          -  metabolic disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kfar-Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2008</verification_date>
  <study_first_submitted>December 2, 2008</study_first_submitted>
  <study_first_submitted_qc>December 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2008</study_first_posted>
  <last_update_submitted>May 2, 2010</last_update_submitted>
  <last_update_submitted_qc>May 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2010</last_update_posted>
  <responsible_party>
    <name_title>Alex Khaikin MD</name_title>
    <organization>Meir Medical Center</organization>
  </responsible_party>
  <keyword>ropivacaine</keyword>
  <keyword>diclofenac</keyword>
  <keyword>local anesthetic instillation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

